Sign in

CIK 0001619856

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Caribou Biosciences, Inc.

Sign in to watch
Ticker
CRBU
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
453728228
Phone
+1 510-982-6030
Business address
2929 7TH STREET, SUITE 105, BERKELEY, CA, 94710
  1. 4 Exercise or conversion Chief Scientific Officer acquired 10,720 shares (option exercise)
  2. 5 Insider Annual Insider Trading Report
  3. 4 Exercise or conversion Chief Financial Officer acquired 24,336 shares (option exercise)
  4. 4 Exercise or conversion President and CEO acquired 10,000 shares (option exercise)
  5. 4 Grant or award Chief Medical Officer acquired 60,000 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market buy VP of Finance and Controller bought 7,387 shares at an average $4.00 ($29,553)
  8. 4/A Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market buy VP of Finance and Controller bought 1,136 shares at $2.69 ($3,056)
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market buy Chief Legal Officer bought 6,127 shares at $2.69 ($16,482)
  20. 4 Derivatives Options or other derivatives

Page 5 of 7 · 125 filings